Atlas Trials

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Clinical trial NCT06274788 · RECRUITING

Trial details

NCT number
NCT06274788
Sponsor
Fresenius Kabi
Status
RECRUITING
Study type
OBSERVATIONAL
Parenteral Nutrition Associated Liver Disease (PNALD)Essential Fatty Acid DeficiencyMalnutritionPediatric ALL
Start date
2024-12-15
Primary completion
2028-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.